Valuation: Teva Pharmaceutical Industries Limited

Market Cap 49.05B 43.93B 40.41B 36.61B 68.43B 4,657B 69.72B 482B 193B 2,450B 184B 180B 7,726B P/E 2026 *
76.7x
P/E 2027 * 25.3x
Enterprise Value 60.38B 54.08B 49.74B 45.07B 84.25B 5,733B 85.82B 593B 238B 3,016B 227B 222B 9,511B EV / Sales 2026 *
3.63x
EV / Sales 2027 * 3.33x
Free-Float
91.17%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Teva Pharmaceutical Industries Limited

Manager TitleAgeSince
Chief Executive Officer 57 01/01/2023
Director of Finance/CFO 53 22/12/2019
Chief Operating Officer 52 03/06/2024
Director TitleAgeSince
Director/Board Member 69 01/01/2009
Chairman 78 06/02/2017
Director/Board Member 65 01/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
5/8/26 Sell

Director

-17 0.0000%
3/8/26 Exercice

Chief Technology Officer

131,066 0.0112%
3/8/26 Exercice

Head of Human Resources

38,481 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%+2.01% - - 48.32B
+3.19%+11.31%+67.86%+150.58% 1,224B
-0.73%+3.56%+44.51%+85.81% 662B
+1.41%+3.24%+29.22%+107.83% 514B
+0.42%+3.20%+54.15%+67.18% 388B
+2.18%+2.93%+73.30%+45.62% 361B
+1.12%+4.52%+35.30%+58.08% 302B
+6.96%+8.86%+11.27%+36.62% 271B
+1.15%+6.09%+59.59%+77.06% 249B
+3.06%+9.38%+44.11%+119.47% 205B
Average +1.76%+3.90%+46.59%+83.14% 464.09B
Weighted average by Cap. +1.18%+5.43%+50.91%+98.22%

Financials

2026 *2027 *
Net sales 16.65B 14.92B 13.72B 12.43B 23.24B 1,581B 23.67B 164B 65.68B 832B 62.5B 61.17B 2,623B 17.23B 15.43B 14.2B 12.86B 24.05B 1,636B 24.5B 169B 67.96B 861B 64.68B 63.3B 2,715B
Net income 893M 799M 735M 666M 1.25B 84.75B 1.27B 8.77B 3.52B 44.58B 3.35B 3.28B 141B 2.24B 2B 1.84B 1.67B 3.12B 212B 3.18B 21.98B 8.82B 112B 8.39B 8.22B 352B
Net Debt 11.33B 10.15B 9.34B 8.46B 15.81B 1,076B 16.11B 111B 44.69B 566B 42.53B 41.63B 1,785B 8.27B 7.41B 6.81B 6.17B 11.54B 785B 11.76B 81.27B 32.62B 413B 31.04B 30.38B 1,303B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Teva Pharmaceutical Industries Limited